Professor Gai Mingying, a well-known scholar in the field of obstetrics and gynecology in China and an expert on gynecological oncology, passed away at the age of 82. She has been engaged in research on women's diseases throughout her life, and is committed to studying the occurrence and development patterns and clinical treatment strategies of obstetric and gynecological tumors. She has won the second prize of the National Natural Science Award, the National Outstanding Scientific and Technological Worker, and other titles, and has been granted multiple national patents. As a well-known expert in the field of obstetrics and gynecology in China, Professor Gai Mingying is one of the important experts in the field of obstetrics, gynecology and urology in my country. She has made important contributions in clinical diagnosis, delivery theory and practice, and reproductive medicine surgery.
Professor Gai Mingying has made outstanding achievements in many fields, including: she discovered and confirmed the existence of ovarian tumors for the first time at home and abroad; she conducted follow-up investigations on domestic patients and discovered for the first time that the ovaries are benign. The incidence of tumors is high, and it is recommended that the disease be treated as an independent disease; she summarized various delivery methods and treatment strategies, including natural uterine delivery and vaginal relaxation after cesarean section, and proposed that natural delivery should be adopted To promote the recovery of pelvic floor function. In the past 30 years, Professor Gai Mingying has persisted in teaching and scientific research on the clinical frontline, and has continuously cultivated high-level talents for the country. As early as 1986, Professor Gai Mingying took the lead in developing assisted reproductive technology to treat infertility in China.
Professor Gai Mingying has in-depth research on gynecological inflammation, especially cervical cancer. She was the first to propose the diagnosis of cervical dysplasia in China. The diagnostic criteria for cervical dysplasia established by her have become the gold standard for gynecological surgery and have important clinical significance in the diagnosis of cervical diseases. In addition, she also made great contributions to the detection of early cervical cancer. In order to detect cervical cancer precancerous lesions early, Professor Gai led the team to conduct in-depth research and analysis on early and mid-stage cervical cancer precancerous lesions. Statistical analysis of a large number of case data shows that the maximum lesion diameter of early cervical cancer is 3 cm or even smaller. This discovery caused great repercussions internationally and provided a new direction for the diagnosis of cervical cancer.